Data de publicação: 28/04/2022 - 15:05
“There are many nuclear missiles in the world. Why don’t we have enough plants to produce vaccines?” The demand came from Adrian Hill, director of the Jenner Institute, of the University of Oxford. One of the main developers of the Oxford/AstraZeneca COVID-19 vaccine, Hill attended the Symposium on Emerging and Persisting Global Health Threats, organized by Fiocruz and by the National Institute of Allergy and Infectious...
Notícias
Data de publicação: 26/04/2022 - 16:04
The Leônidas & Maria Deane Institute (Fiocruz Amazônia), in a partnership with the Tropical Medicine Foundation (FMT), is participating in a pre-clinical trial project for a vaccine against the vivax variety of malaria. The project has just had its sponsoring approved by the Global Health Innovative Technology Fund (GHIT) of Japan. The research is coordinated by researcher Shigeto Yoshida, of the University of Kanazawa, and its...
Notícias
Data de publicação: 26/04/2022 - 15:15
Fiocruz Ceará will welcome a researcher from Pasteur Institute and begin integrated research works aiming at setting up the Fiocruz-Pasteur Platform at the Oswaldo Cruz Foundation campus in Eusébio, in Fortaleza’s Metropolitan Area, in the state of Ceará. The announcement was made by the representative of the Ministry for Europe and Foreign Affairs of France, Leandro Batista, during the event that gathered scientists...
Notícias
Data de publicação: 25/04/2022 - 15:40
For the World Chagas Disease Day, celebrated on April 14, Fiocruz organized a series of activities last week. Among the actions are two online events with lectures and debates about the challenges and possibilities to fight the disease. Last Monday, on one of these occasions, the theme series Memorias of the Oswaldo Cruz Institute was launched, with 15 reflection papers by authors from all over the world and from different areas of knowledge...
Notícias
Data de publicação: 14/04/2022 - 14:16
Last Monday, April 11, was the first day of the international workshop Innovation by Entrepreneurship, promoted by Fiocruz in a partnership with the Pasteur Institute. The purpose of the event, which will continue on Tuesday, April 12, is to present the results of entrepreneurship initiatives of both institutions and to promote a debate between their researchers. Marco Krieger, Fiocruz vice-president of Production and Innovation in Health,...
Notícias
Data de publicação: 13/04/2022 - 15:05
Delegations from the Danish government and the National Institute of Industrial Property (Inpi) visited Fiocruz last Wednesday (4/6) as part of cooperation activities for innovation in Health between Brazil and the European country. The cooperation relationship is in phase 2, dedicated to the health issue, and, following an invitation from Inpi, Fiocruz has been participating in the project. The Foundation's delegations and representatives...
Notícias
Data de publicação: 12/04/2022 - 17:58
A new study by Fiocruz, published in Lancet Infectious Diseases last Thursday (March 31), shows that even people with previous infection by Sars-CoV-2 have higher protection levels when vaccinated. The highest effectiveness was observed with the four vaccines in use in Brazil (Coronavac, AstraZeneca, Janssen, and Pfizer-BioNTech) in the prevention of COVID-19. The research shows increased protection against infection and, in particular, against...
Notícias
Data de publicação: 12/04/2022 - 17:33
Released this Friday (April 4), the Fiocruz COVID-19 Observatory Report shows maintenance of the falling trend of COVID-19 incidence and mortality indicators. The document highlights that for the first time since May 2020, no Brazilian state has exceeded 0.3 deaths per 100,000 inhabitants. The researchers state that according to these new data it is possible to say that the third epidemic wave in Brazil, with a predominance of Omicron among the...
Notícias
Data de publicação: 12/04/2022 - 12:16
Fiocruz hosted, on March 21st, 2022, a meeting that celebrated the victorious partnership in the field of health surveillance. In November 2021, the city of São José dos Pinhais, in the state of Paraná, received the Guangzhou award along with nine other towns around the world. The award selects innovatives approaches adopted by local and regional governments to reach the Sustainable Development Goals (SDG), thus improving...
Notícias
Data de publicação: 08/04/2022 - 15:33
Last Tuesday (March 29), Fiocruz and Drugs for Neglected Diseases initiative (DNDi) signed a Memorandum of Understanding for dengue fever research and treatment. The occasion also sealed a Strategic Research Alliance between the two institutions and the joint submission of a project to the Finep Public Call for Neglected Diseases.
In addition to signing the Memorandum of Understanding for dengue fever, the occasion sealed a Strategic...
Notícias
Data de publicação: 04/04/2022 - 12:55
The international partnerships at Fiocruz are governed by various collaborative agreements. The following is a list of the agreements currently in force.
North-South
In France, FIOCRUZ is the only Brazilian institution that belongs to the Pasteur World Network, which maintains projects with the Alliance Nationale pour les Sciences de la Vie et la Santé (Aviesan), a French national institution that includes the Institut...
Páginas Institucionais (antigas)
Data de publicação: 04/04/2022 - 12:54
The operational activities pertaining to international exchange feature drafting agreements, contracts, and/or memoranda of understanding with institutions from partner countries, procedures for time spent abroad, orientation on applications for special passports and requests for third party notes, and receiving foreign colleagues at the Foundation.
International Agreements
These are formal instruments for establishing and strengthening...
Páginas Institucionais (antigas)
Data de publicação: 31/03/2022 - 18:30
The implementation of a World Health Organization (WHO) hub for Pandemic and Epidemic Intelligence led the WHO to organize the visit of a top-level delegation, together with the Pan-American Health Organization (PAHO), to Fiocruz last Thursday (March 24). Led by the assistant director-general of the Division of Intelligence and Surveillance Systems for Emergencies in Health, Chikwe Ihekweazu, who is also the director of the hub, and Socorro...
Notícias
Data de publicação: 30/03/2022 - 10:15
In a meeting promoted on March 28, by the Center for International Relations in Health (Cris/Fiocruz) and the Vice-Presidencies of Research and Biological Collections (VPPCB) and Education, Information and Communication (VPEIC), members of the Consulate General of the United States in Rio de Janeiro continued the partnership process initiated in 2021. The aim is to expand scientific cooperation between Fiocruz and American institutions....
Notícias
Data de publicação: 25/03/2022 - 16:07
By means of the Immunobiological Technology Institute (Bio-Manguinhos), Fiocruz has been selected by the Ministry of Health to represent Brazil at the BRICS Center of Vaccine Research and Development. Launched this Tuesday (March 22) by the group of countries made up by Brazil, Russia, India, China and South Africa, the goal of the initiative is to share experiences, information and training, so as to strengthen the productive capacity of the...
Notícias
Data de publicação: 24/03/2022 - 15:43
At a meeting that took place last Friday (March 19), representatives of Fiocruz and of the Deutsche Forschungsgemeinschaft (DFG), a German non-profit organization that stimulates research, got together to strengthen bilateral cooperation between the institutions and to discuss possible foment partnerships. As a first step in this direction, a workshop was suggested to evaluate the opportunities, identifying possibilities among ongoing projects...
Notícias
Data de publicação: 23/03/2022 - 16:44
Unitaid, the global health agency connected to the WHO, will be financing the implementation of the project for Injectable Pre-Exposure Prophylaxy in Brazil, using long-acting Cabotegravir. With only six injections per year, the method has proven to be more effective than daily oral PrEP in terms of reducing the risk of infection by the virus. The project will be coordinated by the Evandro Chagas National Infectiology Institute (INI/Fiocruz) in...
Notícias
Data de publicação: 23/03/2022 - 16:42
A study by researchers of Fiocruz and of the University of Columbia has identified promising results in a combination of antiviral drugs for the treatment of COVID-19. Scientists showed that there is a synergy between the substances, inhibiting the enzymes that allow Sars-CoV-2 to multiply more effectively. Together, the drugs may reduce viral replication about ten times more than if taken separately.
The drugs studied are already...
Notícias
Data de publicação: 21/03/2022 - 17:54
The war in Ukraine has been thoroughly divulged, discussed, and explained on all social media platforms, in Brazil and abroad. Its geopolitical, economic, and social consequences have also been explored by specialists of all fields of knowledge and geographical position. However, there is one dimension that has been left out by this widely encompassing debate: the matter of health.
On the other hand, more attentive readers will certainly not...
Notícias
Data de publicação: 21/03/2022 - 12:54
Diseases transmitted from animals to humans, such as spotted fever, Q fever, hantavirus diseases, and arenavirus diseases present early clinical symptoms that are similar to those of other infections, including fever, headache, or aches in the body, and malaise. Amidst an epidemic, when all eyes are focused on diseases that are circulating widely, such as dengue fever or Covid-19, these zoonoses are often forgotten when diagnosing a patient....
Notícias
Data de publicação: 16/03/2022 - 14:24
The Global Network of Human Milk Banks (rBLH) has already started organizing the celebrations of World Human Milk Donation Day - 19 May. The first step consists in choosing the slogan for social mobilization for the donation of human milk in 2022.
Applications must be submitted between the 14th and the 25th of March.
“Human Milk Donation: Solidarity and Peace in a Globalized World” is the theme of social mobilization chosen for...
Notícias
Data de publicação: 16/03/2022 - 11:20
Through the Institute of Drug Technology (Farmanguinhos) and French laboratory Servier, Fiocruz signed, last Thursday (March 10th), a Memorandum of Understanding for technical cooperation to develop new drugs against chronic diseases, from a new pharmaceutical platform. This is an innovative technology based on the prolonged release of the active ingredient in the body, resulting in efficacy, safety, and more compliance and practicality for...
Notícias
Data de publicação: 15/03/2022 - 13:35
In reference to International Women’s Day, the Pasteur Institute, in Paris, paid homage to five female scientists that are part of the institution's international scientific cooperation network. Among them, representing the Americas, was researcher Teca Galvão, from the Laboratory for Functional Genomics and Bioinformatics of the Oswaldo Cruz Institute (IOC/Fiocruz).
The homage highlighted the specialist’s education,...
Notícias
Data de publicação: 14/03/2022 - 12:25
An article published in Nature Biomedical Engineering, last Monday (March 7th), reveals the potential use of synthetic biosensors in rapid, decentralized, and low-cost tests for the diagnosis of patients infects with the zika virus. The study was led by scientists of the University of Toronto (CA), who developed the sensors and the portable digital platform where samples are processed, and had the partnership of researchers from Fiocruz...
Notícias
Data de publicação: 14/03/2022 - 11:43
March is celebrated as the month of International Women’s Day, but it is also the time to debate gender inequalities and guarantee of rights. This issue was highlighted by the ambassador of UN Women for Latin America, María del Carmen Squeff, at the Advanced Seminar in Global Health and Health Diplomacy of the Fiocruz Global Health Center (CRIS/Fiocruz), last Wednesday (March 9th). At the event, which was attended by researchers in...
Notícias
O conteúdo deste portal pode ser utilizado para todos os fins não comerciais, respeitados e reservados os direitos morais dos autores.
